Log in
OTCMKTS:PHMMF

Pharma Mar News Headlines

$124.45
0.00 (0.00 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$124.45
Now: $124.45▼
$124.45
50-Day Range
$92.30
MA: $125.12▼
$156.00
52-Week Range
$23.40
Now: $124.45▼
$158.75
Volume1 shs
Average Volume188 shs
Market Capitalization$2.29 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.31

Headlines

Pharma Mar (OTCMKTS PHMMF) News Headlines Today

Source:
DateHeadline
Pharma Mar (OTCMKTS:PHMMF) Sets New 1-Year High at $158.75Pharma Mar (OTCMKTS:PHMMF) Sets New 1-Year High at $158.75
americanbankingnews.com - October 16 at 6:40 PM
Head to Head Review: Pharma Mar (OTCMKTS:PHMMF) vs. Yara International ASA (OTCMKTS:YARIY)Head to Head Review: Pharma Mar (OTCMKTS:PHMMF) vs. Yara International ASA (OTCMKTS:YARIY)
americanbankingnews.com - October 15 at 8:14 AM
Pharma Mar (OTCMKTS:PHMMF) Shares Up 3%Pharma Mar (OTCMKTS:PHMMF) Shares Up 3%
americanbankingnews.com - October 15 at 12:12 AM
Cambio en el Ibex: PharmaMar ocupará el puesto de Ence el 21 de septiembreCambio en el Ibex: PharmaMar ocupará el puesto de Ence el 21 de septiembre
msn.com - September 11 at 3:14 AM
Pharma Mar, S.A. (PHMMF)Pharma Mar, S.A. (PHMMF)
finance.yahoo.com - May 26 at 7:34 PM
PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19
finance.yahoo.com - April 28 at 7:37 AM
The Pharma Mar (BME:PHM) Share Price Is Up 157% And Shareholders Are Boasting About ItThe Pharma Mar (BME:PHM) Share Price Is Up 157% And Shareholders Are Boasting About It
finance.yahoo.com - March 21 at 8:39 AM
Spains PharmaMar receives CE approval for coronavirus diagnostic kitsSpain's PharmaMar receives CE approval for coronavirus diagnostic kits
www.lse.co.uk - March 6 at 2:05 PM
FDA accepts PharmaMars lurbinectedin application for lung cancerFDA accepts PharmaMar's lurbinectedin application for lung cancer
seekingalpha.com - February 18 at 9:07 AM
PharmaMar and Jazz Pharmaceuticals Announce FDA...PharmaMar and Jazz Pharmaceuticals Announce FDA...
www.benzinga.com - February 17 at 7:42 AM
PharmaMar and Bionical Emas Launch Expanded Access Program for Lurbinectedin in Relapsed Small Cell Lung Cancer in the U.S.PharmaMar and Bionical Emas Launch Expanded Access Program for Lurbinectedin in Relapsed Small Cell Lung Cancer in the U.S.
www.prnewswire.com - January 27 at 1:03 PM
Analysts Expect Breakeven For Pharma Mar, S.A. (BME:PHM)Analysts Expect Breakeven For Pharma Mar, S.A. (BME:PHM)
finance.yahoo.com - January 21 at 7:22 AM
Are Insiders Buying Pharma Mar, S.A. (BME:PHM) Stock?Are Insiders Buying Pharma Mar, S.A. (BME:PHM) Stock?
finance.yahoo.com - December 6 at 9:04 AM
Does Pharma Mar, S.A. (BME:PHM) Have A High Beta?Does Pharma Mar, S.A. (BME:PHM) Have A High Beta?
finance.yahoo.com - October 1 at 8:43 AM
Pharma Mar (BME:PHM) Is Making Moderate Use Of DebtPharma Mar (BME:PHM) Is Making Moderate Use Of Debt
finance.yahoo.com - August 29 at 6:24 PM
Global Dermal Filler Medical Devices Pipeline Assessment 2019: Products Under Development, Companies & Products, and Recent Developments - ResearchAndMarkets.com - Business WireGlobal Dermal Filler Medical Devices Pipeline Assessment 2019: Products Under Development, Companies & Products, and Recent Developments - ResearchAndMarkets.com - Business Wire
www.businesswire.com - February 25 at 6:10 PM
This page was last updated on 10/25/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.